Aldeyra Therapeutics Inc. buy BiotechBee
Start price
01.10.23
/
70%
€6.42
Target price
30.11.25
€10.00
Performance (%)
-73.55%
End price
16.10.23
€1.70
Summary
This prediction ended on 16.10.23 with a price of €1.70. The BUY prediction by BiotechBee for Aldeyra Therapeutics Inc. performed very badly with a performance of -73.55%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aldeyra Therapeutics Inc. | 0.000% | 0.000% | -36.746% |
| iShares Core DAX® | 1.110% | 3.983% | 5.623% |
| iShares Nasdaq 100 | 3.273% | 5.224% | 41.156% |
| iShares Nikkei 225® | 5.782% | 11.577% | 64.348% |
| iShares S&P 500 | 1.635% | 2.445% | 27.360% |
According to BiotechBee what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0